Sesen Bio (SESN) Peer Comparison

$0.63

$-11.09 (-94.64%)

As on 07-Mar-2023 16:00EDT

Market cap

$128 Mln

Revenue (TTM)

$80 Mln

P/E Ratio

--

P/B Ratio

0.6

Div. Yield

0 %

Edit

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Market cap ($ Mln)	128	2,928	2,262	2,152	1,111
Revenue ($ Mln)	40	450	120	549	4
Net Profit ($ Mln)	-19.88	-188.21	-57.50	17.88	-340.16
Net Margin (%)	-24.59	-41.86	-144.33	3.26	-540.52
RoE (%)	-12.05	-28.46	-9.86	1.43	501.41
Price to Earnings	--	--	--	123.80	--
Price-To-Book	0.64	4.96	4.15	1.71	2.10

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Operating Revenue	40.00	215.04	10.21	426.41	12.18
Cost of Revenue	--	74.02	63.57	311.10	1.00
Gross Profit	--	141.02	-53.36	115.31	12.18
Operating Expenses	78.38	545.38	90.79	834.10	69.29
Operating Profit (EBIT)	-25.91	-404.36	-80.57	-718.80	-57.11
Other Income	--	--	--	--	--
Profit before Tax	-23.76	-443.29	-91.59	-360.67	-54.29
Provision for Tax	-3.88	0.22	-0.24	-0.28	-0.02
Profit after Tax (Net Income)	-19.88	-443.29	-91.35	-360.84	-54.27
Minority Interest	--	--	--	--	--
Consolidated Profit	--	-443.29	-91.35	-360.84	--

Liabilities ($ Mln)

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Shareholder's Funds	158.19	1,045.60	497.04	610.37	45.48
Minority Interest	--	--	--	--	--
Non-Current Liabilities	0.00	34.70	113.73	38.67	39.83
Current Liabilities	30.98	139.84	51.37	353.90	30.70
Total Liabilities	189.17	1,220.14	662.14	1,029.45	116.00

Assets ($ Mln)

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Non-Current Assets	0.03	95.80	592.31	189.56	9.62
Current Assets	189.14	1,124.34	69.84	839.89	106.38
Total Assets	189.17	1,220.14	662.14	1,029.45	116.00
Total Debt*	--	20.39	106.91	27.01	34.51
Net Current Assets	158.16	984.49	18.46	485.99	75.68

Cashflow ($ Mln)

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Cash From Operating Activities	0.02	-367.64	-65.78	-268.60	-44.93
Cash Flow from Investing Activities	--	420.02	-0.23	296.59	8.87
Cash from Financing Activities	0.00	-1.73	-9.87	-82.76	37.27
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
ROCE (%)	-12.05	-36.02	-14.15	-43.39	-60.65
ROE (%)	-12.05	-36.55	-16.94	-45.18	-80.80
ROA (%)	-9.25	-31.33	-12.99	-30.04	-45.61
EBIT Margin (%)	--	--	--	--	--
Net Margin (%)	-49.71	-206.14	-894.59	-84.62	-445.64
Cash Profit Margin (%)	--	--	--	--	--

Growth Ratios

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Revenue Growth (%)	0.51	0.49	0.37	0.20	1.90
EBIT Growth (%)	--	--	--	--	--
Net Profit Growth (%)	-5,817.86	37.08	7.55	-85.38	-9.34
EPS Growth (%)	--	0.37	0.08	-0.88	-0.03
Book Value Growth (%)	--	--	--	--	--

Valuation Ratios

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Price / Earnings	--	-66.48	-1.58	-6.92	-3.45
Price / Book Value	--	28.19	0.29	4.09	4.12
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	3.28	-65.50	-2.50	-5.26	-2.42
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Debt to Equity	--	0.02	0.22	0.04	0.76
Short term debt to equity ratio	--	0.01	0.02	0.01	0.13
Current Ratio	6.10	8.04	1.36	2.37	3.47
Quick Ratio	--	7.81	--	2.21	3.45
Interest Coverage	--	-30.38	-4.68	-628.48	-80.78

Operating Efficiency Ratios

	Sesen Bio (SESN)	Zai Lab - ADR	Mesoblast - ADR	HUTCHMED (China) - ADR	Inventiva Sa (IVA)
Debtors to sales (%)	2.06	22.59	43.12	29.72	2.29
Asset Turnover	0.19	0.15	0.01	0.36	0.10
Receivable days	115.59	87.80	160.84	117.55	177.93
Inventory Days	--	124.78	-1.45	54.27	140.41
Payable days	--	474.06	122.60	65.92	6,233.29
Cash Conversion Cycle	--	-261.49	36.79	105.89	-5,914.95

Annual
Quarterly